Tag: USPharmaMarket
-
Lupin Receives USFDA Establishment Inspection Report for New Jersey Facility: A Positive Milestone Amidst Strong Financial Performance
Lupin has successfully received the Establishment Inspection Report (EIR) from the USFDA for its Somerset facility in New Jersey. This milestone highlights the company’s dedication to maintaining high-quality manufacturing standards and strengthens its position in global pharmaceutical markets.
-
Natco Pharma Secures Approval for Generic Everolimus Tablets for Oral Suspension in the U.S.
Natco Pharma has received FDA approval for its generic version of Everolimus tablets for oral suspension (TFOS), providing a more affordable treatment option for patients with TSC-related SEGA. This approval marks a significant milestone in the generics market, offering greater access to a critical therapy for both adult and pediatric patients.